Literature DB >> 12556551

Antiretroviral therapy during pregnancy and the risk of an adverse outcome.

Claire Thorne, Simona Fiore, Christoph Rudin.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12556551     DOI: 10.1056/NEJM200301303480519

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

Review 1.  Surveillance monitoring for safety of in utero antiretroviral therapy exposures: current strategies and challenges.

Authors:  Rebecca M Zash; Paige L Williams; Jeanne Sibiude; Hermione Lyall; Fatima Kakkar
Journal:  Expert Opin Drug Saf       Date:  2016-09-06       Impact factor: 4.250

2.  Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy.

Authors:  Kunjal Patel; David E Shapiro; Susan B Brogly; Elizabeth G Livingston; Alice M Stek; Arlene D Bardeguez; Ruth E Tuomala
Journal:  J Infect Dis       Date:  2010-04-01       Impact factor: 5.226

Review 3.  Antiretroviral Therapy and Pregnancy Outcomes in Developing Countries: A Systematic Review.

Authors:  Fekadu Mazengia Alemu; Alemayehu Worku Yalew; Mesganaw Fantahun; Eta Ebasi Ashu
Journal:  Int J MCH AIDS       Date:  2015

4.  Progesterone supplementation for HIV-positive pregnant women on protease inhibitor-based antiretroviral regimens (the ProSPAR study): a study protocol for a pilot randomized controlled trial.

Authors:  Kaitlin Siou; Sharon L Walmsley; Kellie E Murphy; Janet Raboud; Mona Loutfy; Mark H Yudin; Michael Silverman; Noor N Ladhani; Lena Serghides
Journal:  Pilot Feasibility Stud       Date:  2016-08-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.